FRM
ABMD

Fox Run Management’s Abiomed Inc ABMD Stock Holding History

Fox Run Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,724
Closed -$778K – 676
2019
Q1 		$778K Buy
+2,724
New +$905K 0.44% 19
2018
Q3 		– Sell
-2,153
Closed -$881K – 887
2018
Q2 		$881K Buy
+2,153
New +$780K 0.28% 60
2018
Q1 		– Sell
-1,679
Closed -$315K – 992
2017
Q4 		$315K Buy
+1,679
New +$313K 0.09% 449
2017
Q3 		– Sell
-4,100
Closed -$588K – 933
2017
Q2 		$588K Buy
+4,100
New +$551K 0.2% 168

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Fox Run Management's ABMD Position: Q2 2019 in Review

Fox Run Management sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 2,724 shares — an estimated $778K sold.

Fox Run Management first reported a position in ABMD in Q2 2017 and held it in 4 quarters. The position peaked at $881K in Q2 2018. 483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Fox Run Management reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Fox Run Management sold 2,724 Abiomed Inc shares in Q2 2019, an estimated $778K.
  • Fox Run Management first reported a position in Abiomed Inc in Q2 2017 and held it in 4 quarters.
  • Fox Run Management's Abiomed Inc position peaked at $881K in Q2 2018.
  • 483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Fox Run Management's 13F filing for Q2 2019, filed 17 Jul 2019.